Live Breaking News & Updates on Radiotherapy

Stay informed with the latest breaking news from Radiotherapy on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Radiotherapy and stay connected to the pulse of your community

#VisualAbstract: Preoperative breast MRI may reduce need for adjuvant radiotherapy for women with unifocal breast cancer

1. There were similar rates of ipsilateral invasive recurrence among the postoperative adjuvant radiotherapy group (group 1) and non-radiotherapy group (group 2). 2. 2% of patients in the total cohort underwent mastectomy and all of them were in the non-radiotherapy group. Evidence Rating Level: 1 (Excellent) Study Rundown: Adjuvant breast radiotherapy is a common practice in early

Australia , Minute-medicine-inc , Rating-level , Breast-conserving-surgery , Early-breast , Between-may , Breast , Breast-cancer , Breast-surgery , Mastectomy , Mri

Kate Middleton Cancer Treatment: Kate Middleton and King Charles's cancer diagnosis: Understanding cancer, treatment plans and what experts say

Princess Catherine revealed a cancer diagnosis in a video message, disclosing she was undergoing "preventative chemotherapy" after major surgery. This follows King Charles III's cancer diagnosis, which led to him starting "regular treatments" while continuing his role as head of state. Cancer is a leading global cause of death, with early detection crucial for better outcomes. Treatments include surgery, chemotherapy, and radiotherapy, with advancements improving survival rates. Catherine's disclosure highlights the importance of early detection and ongoing research in fighting cancer.

United-kingdom , London , City-of , New-york , United-states , Buckingham-palace , Westminster , American , Eric-winer , Elena-ratner , Kate-middleton , Michael-birrer

Preoperative breast MRI may reduce need for adjuvant radiotherapy for women with unifocal breast cancer

1. There were similar rates of ipsilateral invasive recurrence among the postoperative adjuvant radiotherapy group (group 1) and non-radiotherapy group (group 2). 2. 2% of patients in the total cohort underwent mastectomy and all of them were in the non-radiotherapy group. Evidence Rating Level: 1 (Excellent) Study Rundown: Adjuvant breast radiotherapy is a common practice

Australia , Rating-level , Breast-conserving-surgery , Early-breast , Between-may , Breast-cancer , Breast-mri , Early-breast-cancer , Mastectomy , Mri , Radiotherapy

External Beam Radiation Therapy for Prostate Cancer

In depth information about various types of external beam radiotherapy for treatment of prostate cancer. Radiotherapy is an alternative to surgical treatment such as radical prostatectomy.

United-states , American , Marie-curie , European-organisation-for-research , American-society-of-therapeutic-radiation-oncology , Radiation-therapy-oncology-group-united-states , Yale-school-of-medicine , External-beam-radiation-therapy , Madam-marie , Main-types , Prostate-cancer , Beam-radiation-therapy

Tata Institute comes up with a ₹100 drug to prevent cancer recurrence

Researchers at the Tata Institute in Mumbai say they've developed a tablet aimed at preventing cancer recurrence. After 10 years of research, they believe that the drug will help prevent cancer from recurring in patients for a second time

Hindustan , India-general- , India , King-charles , Indraneel-mittra , Queen-camilla , Prince-harry , Hindustan-times , Tata-institute-of-social-sciences , Tata-institute , Cancer-drug

#VisualAbstract: Stereotactic body radiotherapy enhances survival in patients with non-small cell lung cancer

1. Median progression-free survival was greater in the SBRT group than in the standard-of-care group. 2. Patients with NSCLC displayed a significant survival benefit with SBRT in comparison to patients with breast cancer. Evidence Rating Level: 1 (Excellent) Study Rundown: Most patients with metastatic breast cancer develop resistance to systemic therapy. Stereotactic body radiotherapy (SBRT) is a

United-states , Minute-medicine-inc , Rating-level , Breast-conserving-surgery , Early-breast , Between-jan , Breast-cancer , Cancer , Lung-cancer , Metastatic-breast-cancer , Non-small-cell-lung-cancer

AstraZeneca Shares Top FTSE 100 Index Risers After Tagrisso Gets U.S. Approval

By Ian Walker AstraZeneca shares are up and leading the FTSE 100 index risers after the company said that its lung-cancer treatment Tagrisso, together with...

United-states , America , Dave-fredrickson , Ian-walker , Astrazeneca , South-america , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Cancer

Stereotactic body radiotherapy enhances survival in patients with non-small cell lung cancer

1. Median progression-free survival was greater in the SBRT group than in the standard-of-care group. 2. Patients with NSCLC displayed a significant survival benefit with SBRT in comparison to patients with breast cancer. Evidence Rating Level: 1 (Excellent) Study Rundown: Most patients with metastatic breast cancer develop resistance to systemic therapy. Stereotactic body radiotherapy (SBRT)

United-states , Rating-level , Breast-conserving-surgery , Early-breast , Between-jan , Breast-cancer , Cancer , Chemotherapy , Lung-cancer , Metastatic-breast-cancer , Non-small-cell-lung-cancer-nsclc-